Journal article
Morbidity and Mortality Weekly Report, vol. 72(3), 2023, pp. 73-75
APA
Click to copy
Sinclair, A. H., Taylor, M. K., Weitz, J. S., Beckett, S., & Samanez-Larkin, G. R. (2023). Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults. Morbidity and Mortality Weekly Report, 72(3), 73–75. https://doi.org/10.15585/mmwr.mm7203a5
Chicago/Turabian
Click to copy
Sinclair, Alyssa H., Morgan K. Taylor, Joshua S. Weitz, Stephen Beckett, and Gregory R. Samanez-Larkin. “Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults.” Morbidity and Mortality Weekly Report 72, no. 3 (2023): 73–75.
MLA
Click to copy
Sinclair, Alyssa H., et al. “Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults.” Morbidity and Mortality Weekly Report, vol. 72, no. 3, 2023, pp. 73–75, doi:10.15585/mmwr.mm7203a5.
BibTeX Click to copy
@article{alyssa2023a,
title = {Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults},
year = {2023},
issue = {3},
journal = {Morbidity and Mortality Weekly Report},
pages = {73-75},
volume = {72},
doi = {10.15585/mmwr.mm7203a5},
author = {Sinclair, Alyssa H. and Taylor, Morgan K. and Weitz, Joshua S. and Beckett, Stephen and Samanez-Larkin, Gregory R.}
}
Bivalent COVID-19 booster vaccines, developed to protect against both ancestral and Omicron BA.4/BA.5 variants, are recommended to increase protection against SARS-CoV-2 infection and severe disease* (1,2). However, relatively few eligible U.S. adults have received a bivalent booster dose (3), and reasons for low coverage are unclear. An opt-in Internet survey of 1,200 COVID-19-vaccinated U.S. adults was conducted to assess reasons for receiving or not receiving a bivalent booster dose. Participants could select multiple reasons from a list of suggested reasons to report why they had or had not received a bivalent booster dose. The most common reasons cited for not receiving the bivalent booster dose were lack of awareness of eligibility for vaccination (23.2%) or of vaccine availability (19.3%), and perceived immunity against infection (18.9%). After viewing information about eligibility and availability, 67.8% of participants who had not received the bivalent booster dose indicated that they planned to do so; in a follow-up survey 1 month later, 28.6% of these participants reported having received the dose. Among those who had planned to receive the booster dose but had not yet done so, 82.6% still intended to do so. Participants who had still not received the booster dose most commonly reported being too busy to get vaccinated (35.6%). To help increase bivalent booster dose coverage, health care and public health professionals should use evidence-based strategies to convey information about booster vaccination recommendations and waning immunity (4), while also working to increase convenient access.